Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Goldschmidt

Showing results (471-480 of 475) with videos related to

Pageof 48
Sort By:
You have reached the last page of results.This site can display upto 475 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple MyelomaRosalinda Termini, David Žihala, Evangelos Terpos, et al.
The Lancet. Oncology|March 4, 2021
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working GroupPhilippe Moreau, Shaji K Kumar, Jesús San Miguel, et al.
Nature Communications|September 15, 2018
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myelomaMolly Went, Amit Sud, Asta Försti, et al.
Nature Communications|January 12, 2019
Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myelomaMolly Went, Amit Sud, Asta Försti, et al.
BMC Cardiovascular Disorders|October 31, 2019
Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9Amand F Schmidt, Michael V Holmes, David Preiss, et al.
Pageof 48

Showing results (471-480 of 475) with videos related to

Sort By:
Pageof 48
You have reached the last page of results.This site can display upto 475 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple MyelomaRosalinda Termini, David Žihala, Evangelos Terpos, et al.
The Lancet. Oncology|March 4, 2021
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working GroupPhilippe Moreau, Shaji K Kumar, Jesús San Miguel, et al.
Nature Communications|September 15, 2018
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myelomaMolly Went, Amit Sud, Asta Försti, et al.
Nature Communications|January 12, 2019
Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myelomaMolly Went, Amit Sud, Asta Försti, et al.
BMC Cardiovascular Disorders|October 31, 2019
Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9Amand F Schmidt, Michael V Holmes, David Preiss, et al.
Pageof 48